Published in Immunol Lett on January 23, 2007
Synergistic effect of TGF-beta superfamily members on the induction of Foxp3+ Treg. Eur J Immunol (2010) 1.13
Mechanisms of emphysema in autosomal dominant cutis laxa. Matrix Biol (2010) 0.99
Differential expression of microRNA and predicted targets in pulmonary sarcoidosis. Biochem Biophys Res Commun (2011) 0.93
Regulation of mu opioid receptor expression in developing T cells. J Neuroimmune Pharmacol (2012) 0.93
Compartmentalization of bone morphogenetic proteins and their antagonists in lymphoid progenitors and supporting microenvironments and functional implications. Immunology (2011) 0.84
Activins and inhibins: novel regulators of thymocyte development. Biochem Biophys Res Commun (2009) 0.83
Identification of stage-specific gene modulation during early thymocyte development by whole-genome profiling analysis after aryl hydrocarbon receptor activation. Mol Pharmacol (2010) 0.83
Approaches to reduce false positives and false negatives in the analysis of microarray data: applications in type 1 diabetes research. BMC Genomics (2008) 0.83
Maintenance of a normal thymic microenvironment and T-cell homeostasis require Smad4-mediated signaling in thymic epithelial cells. Blood (2008) 0.82
Different gene-expression profiles for the poorly differentiated carcinoma and the highly differentiated papillary adenocarcinoma in mammary glands support distinct metabolic pathways. BMC Cancer (2008) 0.81
Transcriptional activation of prostate specific homeobox gene NKX3-1 in subsets of T-cell lymphoblastic leukemia (T-ALL). PLoS One (2012) 0.80
RNA interference-mediated knockdown of CD49e (α5 integrin chain) in human thymic epithelial cells modulates the expression of multiple genes and decreases thymocyte adhesion. BMC Genomics (2010) 0.79
Inhibins tune the thymocyte selection process by regulating thymic stromal cell differentiation. J Immunol Res (2015) 0.78
Betaglycan (TβRIII) is expressed in the thymus and regulates T cell development by protecting thymocytes from apoptosis. PLoS One (2012) 0.77
Modulation of bone morphogenic protein signaling in T-cells for cancer immunotherapy. J Immunotoxicol (2013) 0.75
Small interfering RNAs (siRNAs) targeting TGF-beta1 mRNA suppress asbestos-induced expression of TGF-beta1 and CTGF in fibroblasts. J Environ Pathol Toxicol Oncol (2009) 0.75
A Key Role for Inhibins in Dendritic Cell Maturation and Function. PLoS One (2016) 0.75
Transcriptome profiles in sarcoidosis and their potential role in disease prediction. Curr Opin Pulm Med (2017) 0.75
The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity (1994) 2.11
When versatility matters: activins/inhibins as key regulators of immunity. Immunol Cell Biol (2011) 0.93
Adhesion molecules in human islet beta-cells. De novo induction of ICAM-1 but not LFA-3. Diabetes (1991) 0.92
Reevaluation of autoantibodies to islet cell membrane in IDDM. Failure to detect islet cell surface antibodies using human islet cells as substrate. Diabetes (1992) 0.91
Entamoeba histolytica cysteine protease 2 (EhCP2) modulates leucocyte migration by proteolytic cleavage of chemokines. Parasite Immunol (2004) 0.84
B7-1 expression by a non-antigen presenting cell-derived tumor. Cancer Res (1995) 0.80
Human islet function after automatic isolation and bovine serum albumin gradient purification. Transplantation (1992) 0.79
Proteolytic cleavage of chemokines by Trypanosoma cruzi's cruzipain inhibits chemokine functions by promoting the generation of antagonists. Immunobiology (2009) 0.78
CCR9+ T cells contribute to the resolution of the inflammatory response in a mouse model of intestinal amoebiasis. Immunobiology (2012) 0.78
CDIP-2, a synthetic peptide derived from chemokine (C-C motif) ligand 13 (CCL13), ameliorates allergic airway inflammation. Clin Exp Immunol (2008) 0.78
T cells are responsive to the simian virus 40 large tumor antigen transgenically expressed in pancreatic islets. J Immunol (1993) 0.78
CD11c decrease in mouse thymic dendritic cells after vanadium inhalation. J Immunotoxicol (2012) 0.77
Inappropriate expression of HLA class II molecules in endocrine epithelial cells: the phenomenon, the new experimental data and comparison with animal models. J Autoimmun (1989) 0.76